Literature DB >> 2435061

The fusion glycoprotein of Sendai virus: sequence analysis of an epitope involved in fusion and virus neutralization.

A Portner, R A Scroggs, C W Naeve.   

Abstract

To localize the amino acid residues on the F glycoprotein that are involved in Sendai virus fusion and virus neutralization, an anti-F monoclonal antibody which inhibits these functions was used to select three antigenic variants. Sequence analysis of the entire F gene of the three variants identified a single mutation that was responsible for the loss of antibody binding. The mutation, a proline to glutamine substitution at residue 399, was at a position in the primary sequence far removed from the hydrophobic F1-NH2 terminus thought to be directly involved in fusion. A synthetic peptide, comprising amino acid sequences in the region of the mutation, bound to the antibody used to select the variants, suggesting that the site of mutation is also the site of antibody binding. This information suggests that in the three-dimensional structure of the F molecule the amino acid residues around proline 399 are located close to the F1-NH2 terminus, and that fusion is directly inhibited by antibody binding. Other less likely alternatives are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435061     DOI: 10.1016/0042-6822(87)90301-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Spring-loaded heptad repeat residues regulate the expression and activation of paramyxovirus fusion protein.

Authors:  Laura E Luque; Charles J Russell
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

2.  Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection.

Authors:  S F Atabani; O E Obeid; D Chargelegue; P Aaby; H Whittle; M W Steward
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge.

Authors:  E Malvoisin; F Wild
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Antigenic structure of human respiratory syncytial virus fusion glycoprotein.

Authors:  J A López; R Bustos; C Orvell; M Berois; J Arbiza; B García-Barreno; J A Melero
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

5.  Identification of amino acids recognized by syncytium-inhibiting and neutralizing monoclonal antibodies to the human parainfluenza type 3 virus fusion protein.

Authors:  K V Coelingh; E L Tierney
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

6.  Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function.

Authors:  J A Beeler; K van Wyke Coelingh
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

7.  Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein.

Authors:  K van Wyke Coelingh; E L Tierney
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

8.  Identification of an amino acid that defines the fusogenicity of mumps virus.

Authors:  K Tanabayashi; K Takeuchi; K Okazaki; M Hishiyama; A Yamada
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

9.  Residues in the heptad repeat a region of the fusion protein modulate the virulence of Sendai virus in mice.

Authors:  Laura E Luque; Olga A Bridges; John N Mason; Kelli L Boyd; Allen Portner; Charles J Russell
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

10.  Molecular characterization of a structural epitope that is largely conserved among severe isolates of a plant virus.

Authors:  H R Pappu; S S Pappu; K L Manjunath; R F Lee; C L Niblett
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.